Artículos de revistas sobre el tema "Fusions ETS"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Fusions ETS".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Smith, Jenny L., Rhonda E. Ries, Yi-Cheng Wang, Amanda R. Leonti, Todd A. Alonzo, Alan S. Gamis, Richard Aplenc et al. "ETS Family Transcription Factor Fusions in Childhood AML: Distinct Expression Networks and Clinical Implications". Blood 138, Supplement 1 (5 de noviembre de 2021): 2356. http://dx.doi.org/10.1182/blood-2021-148894.
Texto completoBarbi de Moura, Michelle, Fadel S. Alyaqoub, Gargi D. Basu, David W. Hall, Jess R. Hoag, Janine R. LoBello, Frederick L. Baehner, Snehal Govind Thakkar y Steven Canfield. "Erythroblast transformation-specific transcription factor fusions in prostate cancer." Journal of Clinical Oncology 41, n.º 6_suppl (20 de febrero de 2023): 224. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.224.
Texto completoStaege, Martin S. y Daniela Max. "Genetics and Epigenetics of the TET-ETS Translocation Network". Genetics & Epigenetics 2 (enero de 2009): GEG.S2815. http://dx.doi.org/10.4137/geg.s2815.
Texto completoWei, Ting, Ji Lu, Tao Ma, Haojie Huang, Jean-Pierre Kocher y Liguo Wang. "Re-Evaluate Fusion Genes in Prostate Cancer". Cancer Informatics 20 (enero de 2021): 117693512110275. http://dx.doi.org/10.1177/11769351211027592.
Texto completoGasi Tandefelt, Delila, Joost Boormans, Karin Hermans y Jan Trapman. "ETS fusion genes in prostate cancer". Endocrine-Related Cancer 21, n.º 3 (20 de marzo de 2014): R143—R152. http://dx.doi.org/10.1530/erc-13-0390.
Texto completoAnderson, Nathaniel D., Richard de Borja, Matthew D. Young, Fabio Fuligni, Andrej Rosic, Nicola D. Roberts, Simon Hajjar et al. "Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors". Science 361, n.º 6405 (30 de agosto de 2018): eaam8419. http://dx.doi.org/10.1126/science.aam8419.
Texto completoButeyn, Nathaniel J., Connor Burke, Eve Gardner, Vincent J. Sartori, Rhonda E. Ries, Todd A. Alonzo, Soheil Meshinchi y Timothy Triche. "Reclassification of ETS Family Transcription Factor Fusions in Pediatric AML Based on Molecular Drivers". Blood 142, Supplement 1 (28 de noviembre de 2023): 4298. http://dx.doi.org/10.1182/blood-2023-189474.
Texto completoLawlor, E. R., J. A. Mathers, T. Bainbridge, D. E. Horsman, A. Kawai, J. H. Healey, A. G. Huvos, J. A. Bridge, M. Ladanyi y P. H. Sorensen. "Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis." Journal of Clinical Oncology 16, n.º 3 (marzo de 1998): 1150–57. http://dx.doi.org/10.1200/jco.1998.16.3.1150.
Texto completoDowning, Nicholas F., Kaitlyn M. Mills y Peter C. Hollenhorst. "Abstract 3033: Oncogenic ETS transcription factors avoid repression by EZH2 and FOXO1 in prostate cancer and Ewing sarcoma". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 3033. http://dx.doi.org/10.1158/1538-7445.am2024-3033.
Texto completoClark, Jeremy P. y Colin S. Cooper. "ETS gene fusions in prostate cancer". Nature Reviews Urology 6, n.º 8 (agosto de 2009): 429–39. http://dx.doi.org/10.1038/nrurol.2009.127.
Texto completoDeneen, Benjamin, Scott M. Welford, Thu Ho, Felicia Hernandez, Irwin Kurland y Christopher T. Denny. "PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS Oncoproteins". Molecular and Cellular Biology 23, n.º 11 (1 de junio de 2003): 3897–908. http://dx.doi.org/10.1128/mcb.23.11.3897-3908.2003.
Texto completoMani, Ram-Shankar, Scott A. Tomlins, Kaitlin Callahan, Aparna Ghosh, Mukesh K. Nyati, Sooryanarayana Varambally, Nallasivam Palanisamy y Arul M. Chinnaiyan. "Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer". Science 326, n.º 5957 (29 de octubre de 2009): 1230. http://dx.doi.org/10.1126/science.1178124.
Texto completoHussain, Maha, Stephanie Daignault-Newton, Przemyslaw W. Twardowski, Costantine Albany, Mark N. Stein, Lakshmi P. Kunju, Javed Siddiqui et al. "Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012". Journal of Clinical Oncology 36, n.º 10 (1 de abril de 2018): 991–99. http://dx.doi.org/10.1200/jco.2017.75.7310.
Texto completoZhang, Yue. "Article Commentary: ETS-FUSions Networking, Triggering and Beyond". Genetics & Epigenetics 3 (enero de 2010): GEG.S4166. http://dx.doi.org/10.4137/geg.s4166.
Texto completoFeng, Felix Y., J. Chad Brenner, Maha Hussain y Arul M. Chinnaiyan. "Molecular Pathways: Targeting ETS Gene Fusions in Cancer". Clinical Cancer Research 20, n.º 17 (23 de junio de 2014): 4442–48. http://dx.doi.org/10.1158/1078-0432.ccr-13-0275.
Texto completoZou, Ying S., Laura Morsberger, Melanie Hardy, Jen Ghabrial, Victoria Stinnett, Jaclyn B. Murry, Patty Long et al. "Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas". Genes 14, n.º 6 (24 de mayo de 2023): 1139. http://dx.doi.org/10.3390/genes14061139.
Texto completoYoshimoto, M., A. M. Joshua, S. Chilton-Macneill, J. Bayani, M. Prasad, N. Fleshner, A. Finelli et al. "Detection of novel variant TMPRSS2 /ERG fusion transcripts suggests independent genomic alterations may underlie origin of multi-centric prostate cancer". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 10029. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10029.
Texto completoHe, Wei, Fukang Sun, Juping Zhao, Dai Jun, Le Xu, Chenghe Wang, Chen Fang et al. "Prevalence and genetic features of TMPRSS2-ERG fusion in Chinese patients with prostate cancer." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e17529-e17529. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e17529.
Texto completoArvand, Afsane y Christopher T. Denny. "Biology of EWS/ETS fusions in Ewing's family tumors". Oncogene 20, n.º 40 (septiembre de 2001): 5747–54. http://dx.doi.org/10.1038/sj.onc.1204598.
Texto completoKhosh Kish, Ealia, Muhammad Choudhry, Yaser Gamallat, Sabrina Marsha Buharideen, Dhananjaya D y Tarek A. Bismar. "The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer". International Journal of Molecular Sciences 23, n.º 9 (26 de abril de 2022): 4772. http://dx.doi.org/10.3390/ijms23094772.
Texto completoKhosh Kish, Ealia, Muhammad Choudhry, Yaser Gamallat, Sabrina Marsha Buharideen, Dhananjaya D y Tarek A. Bismar. "The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer". International Journal of Molecular Sciences 23, n.º 9 (26 de abril de 2022): 4772. http://dx.doi.org/10.3390/ijms23094772.
Texto completoZhang, Zhusheng, Qiyuan Bao, Junxiang Wen, Zhuochao Liu, Qi Liu, Yuhui Shen, Lin Shao, Bing Li, Song-An Chen y Weibin Zhang. "Abstract 4545: Integrative immune-genomic comparison of canonical Ewing sarcoma with Ewing-like mimics identifies potential targets for personalized therapies". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 4545. http://dx.doi.org/10.1158/1538-7445.am2023-4545.
Texto completoLe Deley, Marie-Cecile, Olivier Delattre, Karl-Ludwig Schaefer, Sue A. Burchill, Gabriele Koehler, Pancras C. W. Hogendoorn, Thomas Lion et al. "Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial". Journal of Clinical Oncology 28, n.º 12 (20 de abril de 2010): 1982–88. http://dx.doi.org/10.1200/jco.2009.23.3585.
Texto completoAnderson, Peter Meade, Luisa-Marie Manning, Brian Rubin, Timothy A. Chan, Scott E. Kilpatrick, Rabi Hanna y Zheng Jin Tu. "Nested set information derived from fusion genes in Ewing sarcoma and other cancers." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): e23521-e23521. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e23521.
Texto completoFeng, Felix Yi-Chung, Scott Tomlins, Mohammed Alshalalfa, Nicholas Erho, Kasra Yousefi, Shuang Zhao, Robert Benjamin Den et al. "Molecular and clinical characterization of 1,577 primary prostate cancer tumors to reveal novel clinical and biological insights into its subtypes." Journal of Clinical Oncology 33, n.º 7_suppl (1 de marzo de 2015): 9. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.9.
Texto completoSmit, F. P., M. Salagierski, D. Hessels, S. A. Jannink y J. A. Schalken. "786 IDENTIFICATION OF ETS GENE FUSIONS USING AFFYMETRIX EXON 1.0 ARRAYS". European Urology Supplements 8, n.º 4 (marzo de 2009): 317. http://dx.doi.org/10.1016/s1569-9056(09)60774-0.
Texto completoHammer, Liat, Ryan Rebernick, Matthew McFarlane, Thomas Westbrook, Munna Hazime, Tanya Hammoud, Pin-en Chiu et al. "Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer." Journal of Clinical Oncology 41, n.º 6_suppl (20 de febrero de 2023): 263. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.263.
Texto completoHo, Jen M. Y., Bryan K. Beattie, Jeremy A. Squire, David A. Frank y Dwayne L. Barber. "Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling". Blood 93, n.º 12 (15 de junio de 1999): 4354–64. http://dx.doi.org/10.1182/blood.v93.12.4354.
Texto completoHo, Jen M. Y., Bryan K. Beattie, Jeremy A. Squire, David A. Frank y Dwayne L. Barber. "Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling". Blood 93, n.º 12 (15 de junio de 1999): 4354–64. http://dx.doi.org/10.1182/blood.v93.12.4354.412k30_4354_4364.
Texto completoYaseen, Nabeel R., Akiko Takeda, Reza Nazari, Helen Shio, Gunter Blobel y Hualin Zhong. "Carrier-Independent Nuclear Import of the Transcription Factor PU.1." Blood 104, n.º 11 (16 de noviembre de 2004): 3561. http://dx.doi.org/10.1182/blood.v104.11.3561.3561.
Texto completoFeng, F. Y., S. Han, C. Brenner, A. Sabolch, D. A. Hamstra, T. S. Lawrence y A. Chinnaiyan. "PARP inhibition reverses radiation resistance conferred by ETS fusions in prostate cancer." Journal of Clinical Oncology 29, n.º 15_suppl (20 de mayo de 2011): 4545. http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4545.
Texto completoTomlins, Scott A., Anders Bjartell, Arul M. Chinnaiyan, Guido Jenster, Robert K. Nam, Mark A. Rubin y Jack A. Schalken. "ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice". European Urology 56, n.º 2 (agosto de 2009): 275–86. http://dx.doi.org/10.1016/j.eururo.2009.04.036.
Texto completoDong, Rongfang, Lan Li, Lihua Gong, Mengmeng Tian, Tingting Zhang, Wen Zhang y Yi Ding. "Abstract 2152: Targetable oncogenic fusions and other alterations in bone and soft-tissue tumors assessed by RNA and DNA-based next-generation sequencing in real-world experience". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 2152. http://dx.doi.org/10.1158/1538-7445.am2023-2152.
Texto completoBilke, Sven, Raphaela Schwentner, Fan Yang, Maximilian Kauer, Gunhild Jug, Robert L. Walker, Sean Davis et al. "Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer". Genome Research 23, n.º 11 (12 de agosto de 2013): 1797–809. http://dx.doi.org/10.1101/gr.151340.112.
Texto completoTomlins, Scott A., Bharathi Laxman, Saravana M. Dhanasekaran, Beth E. Helgeson, Xuhong Cao, David S. Morris, Anjana Menon et al. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer". Nature 448, n.º 7153 (agosto de 2007): 595–99. http://dx.doi.org/10.1038/nature06024.
Texto completoDehm, Scott M. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer". Urologic Oncology: Seminars and Original Investigations 26, n.º 6 (noviembre de 2008): 687–88. http://dx.doi.org/10.1016/j.urolonc.2008.09.003.
Texto completoDong, Jun, Li Xiao, Lu Sheng, Jun Xu y Zhong-Quan Sun. "TMPRSS2:ETS Fusions and Clinicopathologic Characteristics of Prostate Cancer Patients from Eastern China". Asian Pacific Journal of Cancer Prevention 15, n.º 7 (1 de abril de 2014): 3099–103. http://dx.doi.org/10.7314/apjcp.2014.15.7.3099.
Texto completoDan, Yuqing, Ruibao Ren, Donghe Li y Ping Liu. "Novel Fusion Gene Aven-NUTM1 Induces Mice Myeloid Leukemia Vulnerable to HDAC Inhibitors". Blood 142, Supplement 1 (28 de noviembre de 2023): 4123. http://dx.doi.org/10.1182/blood-2023-188034.
Texto completoCools, Jan, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer y Peter Marynen. "Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)". Blood 94, n.º 5 (1 de septiembre de 1999): 1820–24. http://dx.doi.org/10.1182/blood.v94.5.1820.
Texto completoCools, Jan, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer y Peter Marynen. "Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)". Blood 94, n.º 5 (1 de septiembre de 1999): 1820–24. http://dx.doi.org/10.1182/blood.v94.5.1820.417k09_1820_1824.
Texto completoThompson, Andrew D., Michael A. Teitell, Afsane Arvand y Christopher T. Denny. "Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells". Oncogene 18, n.º 40 (septiembre de 1999): 5506–13. http://dx.doi.org/10.1038/sj.onc.1202928.
Texto completoBraunreiter, Chi L., Jeffery D. Hancock, Cheryl Coffin, Kenneth M. Boucher y Stephen L. Lessnick. "Expression of EWS-ETS Fusions in NIH3T3 Cells Reveals Significant Differences to Ewing’s Sarcoma". Cell Cycle 5, n.º 23 (17 de noviembre de 2006): 2753–59. http://dx.doi.org/10.4161/cc.5.23.3505.
Texto completoPaulo, Paula, João D. Barros-Silva, Franclim R. Ribeiro, João Ramalho-Carvalho, Carmen Jerónimo, Rui Henrique, Guro E. Lind, Rolf I. Skotheim, Ragnhild A. Lothe y Manuel R. Teixeira. "FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer". Genes, Chromosomes and Cancer 51, n.º 3 (12 de noviembre de 2011): 240–49. http://dx.doi.org/10.1002/gcc.20948.
Texto completoSeligson, Nathan David, Richard D. Maradiaga, Colin W. Stets, Howard Katzenstein, Sherri Z. Millis, John L. Hays y James Lin Chen. "Multiscale omic assessment of EWSR1-NFATc2 fusion positive sarcomas to identify conserved fusion breakpoint and activation of the mTOR pathway." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e23536-e23536. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e23536.
Texto completoGUO, Xiao-Qiang, Yao-Ting GUI y Zhi-Ming CAI. "The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer". Hereditas (Beijing) 33, n.º 2 (5 de mayo de 2011): 117–22. http://dx.doi.org/10.3724/sp.j.1005.2011.00117.
Texto completoPflueger, D., S. Terry, A. Sboner, L. Habegger, R. Esgueva, P. C. Lin, M. A. Svensson et al. "Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing". Genome Research 21, n.º 1 (29 de octubre de 2010): 56–67. http://dx.doi.org/10.1101/gr.110684.110.
Texto completoMiyagi, Yohei, Takeshi Sasaki, Kiyoshi Fujinami, Jinyu Sano, Yutaka Senga, Takeshi Miura, Yoichi Kameda et al. "ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples". Modern Pathology 23, n.º 11 (6 de agosto de 2010): 1492–98. http://dx.doi.org/10.1038/modpathol.2010.149.
Texto completoXu, Kemin, Alexandra Budhai, Rugved Pattarkine y Minghao Zhong. "Detecting FLI1 Fusion by Immunohistochemistry (IHC) Stain in Prostatic Adenocarcinoma". American Journal of Clinical Pathology 152, Supplement_1 (11 de septiembre de 2019): S72—S73. http://dx.doi.org/10.1093/ajcp/aqz113.087.
Texto completoNakagawa, Hidewaki. "Prostate cancer genomics by high-throughput technologies: genome-wide association study and sequencing analysis". Endocrine-Related Cancer 20, n.º 4 (26 de abril de 2013): R171—R181. http://dx.doi.org/10.1530/erc-13-0113.
Texto completoMorris, David S., Scott A. Tomlins, Daniel R. Rhodes, Jianjun Yu, Mark A. Rubin, Anders S. Bjartell y Arul M. Chinnaiyan. "OUTLIER EXPRESSION OF SPINK1 IDENTIFIES AN AGGRESSIVE MOLECULAR SUBTYPE IN PROSTATE CANCERS WITHOUT ETS GENE FUSIONS". Journal of Urology 179, n.º 4S (abril de 2008): 707. http://dx.doi.org/10.1016/s0022-5347(08)62060-1.
Texto completo